DGAP-News: SphingoTec Accelerates Growth with Direct Sales
vom 20.05.2021, 10:00 Uhr
Bild: pixabay.com
SphingoTec Accelerates Growth with Direct Sales
20.05.2021 / 10:00
The issuer is solely responsible for the content of this announcement.
SphingoTec to expand the commercialization strategy by establishing a sales division and appointing new head of sales
Tailored diagnostic solutions for point of care use
Innovative proprietary biomarkers and standard parameters available on the fully automated Nexus IB10 platform
Hennigsdorf/Berlin, Germany, May 20, 2021 - Diagnostics company SphingoTec GmbH ( SphingoTec ) announces an expansion of its go-to-market strategy to scale its sales in Germany by creating a direct sales force for its integrated diagnostic solutions. SphingoTec will sell directly to healthcare providers its Nexus IB10 point of care platform together with a broad portfolio of assays. The rapid tests include commonly used parameters as well as innovative and pro
DGAP-News: SphingoTec GmbH / Key word(s): Corporate Action/Strategic Company Decision SphingoTec Accelerates Growth with Direct Sales 20.05.2021 / 10:00 The issuer is solely responsible